(Q39208620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Kjell-Arne Ung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Hans Törnblom

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mats Rudling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Magnus Simrén

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

English

0 references

publication date

12 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

84-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24727487%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and management of IBS.

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Colonic transit time and IBS symptoms: what's the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Elevated motility-related transmucosal potential difference in the upper small intestine in the irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Mechanisms in IBS: something old, something new, something borrowed...

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

The proximal colonic motor response to rectal mechanical and chemical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Effect of glycine-conjugated bile acids with and without lecithin on water and glucose absorption in perfused human jejunum

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Bile acids: short and long term effects in the intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Methods for diagnosis of bile acid malabsorption in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Mini-review: endocrine actions of fibroblast growth factor 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Bile acids: regulation of synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Long-term course in collagenous colitis and the impact of bile acid malabsorption and bile acid sequestrants on histopathology and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

An Irritable Bowel Syndrome-Specific Symptom Questionnaire: Development and Validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Design of treatment trials for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Colonoscopy and SeHCAT for investigation of chronic diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): fact or fiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Efficient diagnosis of suspected functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Elobixibat for the treatment of constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Brain-gut axis: from basic understanding to treatment of IBS and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

High body mass alters colonic sensory-motor function and transit in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965

Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305965